Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemirolast in Allergic Asthma
NCT03119714Phase 2Terminated
- Sponsor
- Karolinska University Hospital
- Start
- Nov 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemirolast in allergic asthma, sponsored by Karolinska University Hospital. Started Nov 2016; status: terminated.
02
Drugs
pemirolast
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT03119714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03119714.